SCNI
Price
$2.55
Change
-$0.70 (-21.54%)
Updated
Jun 6 closing price
Capitalization
3.07M
WINT
Price
$0.57
Change
-$0.02 (-3.39%)
Updated
Jun 6 closing price
Capitalization
2.12M
Interact to see
Advertisement

SCNI vs WINT

Header iconSCNI vs WINT Comparison
Open Charts SCNI vs WINTBanner chart's image
Scinai Immunotherapeutics
Price$2.55
Change-$0.70 (-21.54%)
Volume$642.7K
Capitalization3.07M
Windtree Therapeutics
Price$0.57
Change-$0.02 (-3.39%)
Volume$242.8K
Capitalization2.12M
SCNI vs WINT Comparison Chart
Loading...
SCNI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WINT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SCNI vs. WINT commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SCNI is a StrongBuy and WINT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (SCNI: $2.73 vs. WINT: $0.84)
Brand notoriety: SCNI and WINT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SCNI: 9% vs. WINT: 20%
Market capitalization -- SCNI: $3.07M vs. WINT: $2.12M
SCNI [@Biotechnology] is valued at $3.07M. WINT’s [@Biotechnology] market capitalization is $2.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SCNI’s FA Score shows that 2 FA rating(s) are green whileWINT’s FA Score has 1 green FA rating(s).

  • SCNI’s FA Score: 2 green, 3 red.
  • WINT’s FA Score: 1 green, 4 red.
According to our system of comparison, SCNI is a better buy in the long-term than WINT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SCNI’s TA Score shows that 5 TA indicator(s) are bullish while WINT’s TA Score has 4 bullish TA indicator(s).

  • SCNI’s TA Score: 5 bullish, 3 bearish.
  • WINT’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, both SCNI and WINT are a good buy in the short-term.

Price Growth

SCNI (@Biotechnology) experienced а -4.53% price change this week, while WINT (@Biotechnology) price change was +6.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SCNI($3.07M) has a higher market cap than WINT($2.12M). SCNI has higher P/E ratio than WINT: SCNI (1.19) vs WINT (0.83). SCNI YTD gains are higher at: -18.365 vs. WINT (-95.191). SCNI has more cash in the bank: 1.03M vs. WINT (917K). SCNI has less debt than WINT: SCNI (1.23M) vs WINT (2.01M).
SCNIWINTSCNI / WINT
Capitalization3.07M2.12M145%
EBITDA7.8MN/A-
Gain YTD-18.365-95.19119%
P/E Ratio1.190.83144%
Revenue452KN/A-
Total Cash1.03M917K113%
Total Debt1.23M2.01M61%
FUNDAMENTALS RATINGS
SCNI vs WINT: Fundamental Ratings
SCNI
WINT
OUTLOOK RATING
1..100
8850
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
58
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
899
PRICE GROWTH RATING
1..100
6098
P/E GROWTH RATING
1..100
724
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SCNI's Valuation (21) in the Pharmaceuticals Major industry is somewhat better than the same rating for WINT (58) in the Biotechnology industry. This means that SCNI’s stock grew somewhat faster than WINT’s over the last 12 months.

SCNI's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as WINT (100) in the Biotechnology industry. This means that SCNI’s stock grew similarly to WINT’s over the last 12 months.

SCNI's SMR Rating (8) in the Pharmaceuticals Major industry is significantly better than the same rating for WINT (99) in the Biotechnology industry. This means that SCNI’s stock grew significantly faster than WINT’s over the last 12 months.

SCNI's Price Growth Rating (60) in the Pharmaceuticals Major industry is somewhat better than the same rating for WINT (98) in the Biotechnology industry. This means that SCNI’s stock grew somewhat faster than WINT’s over the last 12 months.

WINT's P/E Growth Rating (4) in the Biotechnology industry is significantly better than the same rating for SCNI (72) in the Pharmaceuticals Major industry. This means that WINT’s stock grew significantly faster than SCNI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SCNIWINT
RSI
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
76%
Bullish Trend 12 days ago
76%
Momentum
ODDS (%)
Bullish Trend 12 days ago
86%
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
88%
Bullish Trend 12 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
77%
Bearish Trend 12 days ago
90%
Advances
ODDS (%)
Bullish Trend 24 days ago
78%
Bullish Trend 12 days ago
76%
Declines
ODDS (%)
Bearish Trend 18 days ago
88%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 12 days ago
82%
Aroon
ODDS (%)
Bullish Trend 12 days ago
70%
Bearish Trend 12 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
SCNI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WINT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

SCNI and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCNI has been closely correlated with WINT. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if SCNI jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCNI
1D Price
Change %
SCNI100%
-5.60%
WINT - SCNI
89%
Closely correlated
+5.12%
NBY - SCNI
88%
Closely correlated
-0.58%
NCNA - SCNI
88%
Closely correlated
-3.85%
SNPX - SCNI
88%
Closely correlated
-10.74%
RNAC - SCNI
86%
Closely correlated
+3.65%
More

WINT and

Correlation & Price change

A.I.dvisor indicates that over the last year, WINT has been closely correlated with CDTX. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if WINT jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WINT
1D Price
Change %
WINT100%
+5.12%
CDTX - WINT
94%
Closely correlated
-5.46%
NCNA - WINT
92%
Closely correlated
-3.85%
SNPX - WINT
92%
Closely correlated
-10.74%
NBY - WINT
92%
Closely correlated
-0.58%
AGEN - WINT
91%
Closely correlated
-14.93%
More